Expansion of HIV screening to non-clinical venues is aided by the use of dried blood spots for Western blot confirmation

Journal of Clinical Virology

Volumn 58, Issue SUPPL1, 2013, Pages

  Sullivan, Timothy J ^a   Antonio Gaddy, Mara San ^b   Richardson Moore, April ^b   Styer, Linda M ^a,c   Bigelow Saulsbery, Deborah ^b   Parker, Monica M ^a  

^a WADSWORTH CENTER   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Confirmation; Dried blood spot; HIV; Rapid testing; Western blot

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRIED BLOOD SPOT TESTING; FEASIBILITY STUDY; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; PAPER; PRIORITY JOURNAL; SCREENING; UNITED STATES; VENOUS BLOOD; WESTERN BLOTTING;

CONFIRMATION; DRIED BLOOD SPOT; HIV; RAPID TESTING; WESTERN BLOT;

ANTIGENS, VIRAL; BLOTTING, WESTERN; CLINICAL LABORATORY TECHNIQUES; DESICCATION; HIV INFECTIONS; HUMANS; NEW YORK; SPECIMEN HANDLING;

EID: 84890192035     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.004     Document Type: Article

References (19)

1. The White House Office of National AIDS Policy National HIV/AIDS strategy for the United States 2010, [accessed 21.05.13]. http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf.
2. Branson B. Current HIV epidemiology and revised recommendations for HIV testing in health-care settings. Journal of Medical Virology 2007, 79(Suppl. 1):S6-S10.
3. Chapter 308 of the laws of 2010 HIV testing law 2010, [accessed 21.05.13]. http://www.health.ny.gov/diseases/aids/testing/law/docs/2010_legislation_and_memo.pdf.
4. New York State Public Health Law Title V, clinical laboratory and blood banking services 2011, [accessed 21.05.13]. http://www.wadsworth.org/labcert/regaffairs/clinical/title5.pdf.
5. Amendments to article 5, Title V public health law, 579 scope and exceptions and 580, construction 2008, [accessed 22.05.13]. http://www.wadsworth.org/labcert/limited/PHL_Amendments.pdf.
6. Behets F., Kashamuka M., Pappaioanou M., Green T.A., Ryder R.W., Batter V., et al. Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. Journal of Clinical Microbiology 1992, 30(5):1179-1182.
7. Farzadegan H., Quinn T., Polk B.F. Detecting antibodies to human immunodeficiency virus in dried blood on filter papers. Journal of Infectious Diseases 1987, 155(5):1073-1074.
8. Varnier O.E., Lillo F.B., Reina S., De Maria A., Terragna A., Schito G. Whole blood collection on filter paper is an effective means of obtaining samples for human immunodeficiency virus antibody assay. AIDS Research and Human Retroviruses 1988, 4(2):131-136.
9. McNulty A., Jennings C., Bennett D., Fitzgibbon J., Bremer J.W., Ussery M., et al. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. Journal of Clinical Microbiology 2007, 45(2):517-521.
10. Torian L.V., Henning K.J., Kellerman S.E., Frieden T.R. Striving toward comprehensive HIV/AIDS surveillance: the view from New York City. Public Health Reports 2007, 122(Suppl. 1):4-6.
11. Mei J.V., Alexander J.R., Adam B.W., Hannon W.H. Use of filter paper for the collection and analysis of human whole blood specimens. Journal of Nutrition 2001, 131(5):1631S-1636S.
12. Granade T.C., Parekh B.S., Tih P.M., Welty T., Welty E., Bulterys M., et al. Evaluation of rapid prenatal human immunodeficiency virus testing in rural Cameroon. Clinical and Diagnostic Laboratory Immunology 2005, 12(7):855-860.
13. Clinical Laboratory Standards Institute (CLSI) Approved guideline-M-53A: criteria for laboratory testing and diagnosis of human immunodeficiency virus infection 2011, Clinical Laboratory Standards Institute (CLSI), Wayne, PA, USA.
14. Bowles K.E., Clark H.A., Tai E., Sullivan P.S., Song B., Tsang J., et al. Implementing rapid HIV testing in outreach and community settings: results from an advancing HIV prevention demonstration project conducted in seven U.S. cities. Public Health Reports 2008, 123(Suppl. 3):78-85.
15. Schulden J.D., Song B., Barros A., Mares-DelGrasso A., Martin C.W., Ramirez R., et al. Rapid HIV testing in transgender communities by community-based organizations in three cities. Public Health Reports 2008, 123(Suppl. 3):101-114.
16. Shrestha R.K., Clark H.A., Sansom S.L., Song B., Buckendahl H., Calhoun C.B., et al. Cost-effectiveness of finding new HIV diagnoses using rapid HIV testing in community-based organizations. Public Health Reports 2008, 123(Suppl. 3):94-100.
17. Centers for Disease Control and Prevention Notice to readers: protocols for confirmation of reactive rapid HIV tests. MMWR Morbidity and Mortality Weekly Report 2004, 53(10):221-222.
18. Masciotra S., McDougal J.S., Feldman J., Sprinkle P., Wesolowski L., Owen S.M. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. Journal of Clinical Virology 2011, 52(Suppl. 1):S17-S22.
19. Styer L.M., Sullivan T.J., Parker M.M. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data. Journal of Clinical Virology 2011, 52(Suppl. 1):S35-S40.